News | January 02, 2008

Physical Activity Impacts Mortality in PAD

January 3, 2008 - A patient’s physical activity status is a significant and robust predictor of all-cause mortality in patients with varying levels of ambulatory function, according to a new study that compares death rates between active and sedentary patients who have peripheral artery disease (PAD) with intermittent claudication published in the January 2008 issue of the Journal for Vascular Surgery.

PAD occurs in more than 20 percent of people over 70 years of age and is usually associated with high blood pressure, diabetes and stroke. It blocks the circulation to vital arteries most often in the legs and feet, and can cause difficulty in walking or even foot ulcers and infections.

However, some patients with PAD also develop intermittent claudication as they walk, resulting from a mismatch between reduced leg and foot circulation and the increased metabolic requirements necessary to walk or exercise.

Intermittent claudication affects five percent of people 55 years and older in the U.S., according to lead researcher Andrew W. Gardner, Ph.D., professor at the Clinical Research Center at the University of Oklahoma Health Sciences in Oklahoma City. “Ambulatory dysfunction limits physical activities of patients and negatively affects their lives,” he said. “As a result, many of these patients take on a sedentary lifestyle and become even more at risk for death.”

Researchers wanted to determine if physical activity can predict mortality in PAD patients and whether those limited by intermittent claudication could increase their life span by engaging in any amount of weekly physical activity compared to being sedentary or doing very light activities.

"We found that after adjusting for age, body mass index (BMI), ankle-brachial index results and other comorbidities, a patient’s physical activity status was a significant and robust predictor of all-cause mortality in patients with varying levels of ambulatory function,” said Dr. Gardner. "Even minimal amounts of physical activity performed at moderate intensity are beneficial and provide protective effects regardless of the ambulatory ability of patients limited by intermittent claudication."

"Incorporating less than one hour of walking each week at a speed faster than normal pace to reduce risk of death may apply equally well to patients who have severe intermittent claudication to those who have milder symptoms," added Dr. Gardner. "It is not clear whether moving faster than normal represents a threshold of intensity that must be attained to impact all-cause mortality, or whether this pace is beneficial simply because it results in a greater volume of physical activity. If the latter is true, it can be speculated that patients who walk at their usual pace, but for longer durations, may reduce their risk of an earlier death as well."

This retrospective study was done at the Geriatrics, Research and Clinical Center at the Maryland Veterans Affairs Health Care System in Baltimore between 1994 and 2002. One hundred and thirty-five physically active patients were compared with 299 patients in the sedentary group, and followed in the 2004 Social Security Death Index. Medical history, including physical function and activity, peripheral circulation, comorbid conditions and cardiovascular risk factors, were recorded for each patient. Additionally, a six-minute walk test was performed.

The median follow-up was 5.33 years for the physically active group, and five years for the sedentary group. One hundred and eight patients (24 percent) had died, consisting of 86 (28 percent) in the sedentary group and 22 (16.3 percent) in the active group.

Very few PAD patients limited by intermittent claudication walk fast, so the majority may have perceived that they performed activities at a moderate level of intensity simply by walking for any duration at a pace faster than normal. Patients classified themselves as being physically active when they did at least some of their activities at an intensity equivalent to fast walking, whereas the sedentary group said they avoid doing physical activity altogether or that they never exceed a light activity such as walking at a normal pace.

Other studies have shown that patients with intermittent claudication have a risk of mortality that is about two-fold higher than those without PAD. Prognosis for PAD patients generally worsens as the severity increases and studies have shown that asymptomatic patients have about half the all-cause mortality risk as those with intermittent claudication.

"The clinical implication of our findings is that PAD patients of varying ages, disease severity and body composition may reduce their heightened risk of mortality by engaging in less than one hour of physical activity each week that exceeds light intensity such as ambulating at speeds faster than their typical pace," added Dr. Gardner.

For more information:

Related Content

FDA Issues Letter About Paclitaxel Coated Balloons and Eluting Stents
News | Peripheral Artery Disease (PAD) | January 17, 2019
The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers regarding a recent...
New Appropriate Use Criteria Released for Peripheral Artery Interventions
News | Peripheral Artery Disease (PAD) | December 19, 2018
A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular professional societies...
Lithotripsy Safe and Effective in Calcified Stenotic Peripheral Arteries
News | Peripheral Artery Disease (PAD) | December 04, 2018
New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt closures with the...
Lutonix 014 Drug-Coated Balloon Safe and Effective Below the Knee
News | Peripheral Artery Disease (PAD) | November 07, 2018
The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a standard percutaneous...
Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018
NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai Medical, a specialty...
PQ Bypass Effective in Treating Extremely Long SFA Lesions at 12 Months
News | Peripheral Artery Disease (PAD) | July 02, 2018
The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long blockages in the...
SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection
News | Peripheral Artery Disease (PAD) | May 15, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the...
SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease
News | Peripheral Artery Disease (PAD) | May 14, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and...
Critical Limb Ischemia Treatment Shows No Improvement at Three Months
News | Peripheral Artery Disease (PAD) | March 23, 2018
Patients with foot ulcers or gangrene who received the experimental drug JVS-100 did not show evidence of faster wound...
Overlay Init